These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 8138449)

  • 1. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities.
    Williamson JF; Perera H; Li Z; Lutz WR
    Med Phys; 1993; 20(1):209-22. PubMed ID: 8455503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Monte Carlo dose calculations near 125I sources in the presence of bounded heterogeneities.
    Das RK; Keleti D; Zhu Y; Kirov AS; Meigooni AS; Williamson JF
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):843-53. PubMed ID: 9240654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ytterbium-169: calculated physical properties of a new radiation source for brachytherapy.
    Mason DL; Battista JJ; Barnett RB; Porter AT
    Med Phys; 1992; 19(3):695-703. PubMed ID: 1508110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo aided room scatter corrections in the air-kerma strength standardization of 169Yb and 60Co brachytherapy sources.
    Selvam TP; Rajan KN; Sethulakshmi P; Bhatt BC
    Phys Med Biol; 2003 Jun; 48(11):N139-47. PubMed ID: 12817945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study.
    Mainegra E; Capote R; López E
    Phys Med Biol; 1998 Jun; 43(6):1557-66. PubMed ID: 9651025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry of 169 Yb seed model X1267.
    Piermattei A; Azario L; Rossi G; Soriani A; Arcovito G; Ragona R; Galelli M; Taccini G
    Phys Med Biol; 1995 Aug; 40(8):1317-30. PubMed ID: 7480115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation evaluation of NIST air-kerma rate calibration standard for electronic brachytherapy.
    Hiatt JR; Rivard MJ; Hughes HG
    Med Phys; 2016 Mar; 43(3):1119-29. PubMed ID: 26936699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo modeling of the transverse-axis dose distribution of the model 200 103Pd interstitial brachytherapy source.
    Williamson JF
    Med Phys; 2000 Apr; 27(4):643-54. PubMed ID: 10798684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo characterization of 169Yb as a high-dose-rate source for brachytherapy application by FLUKA code.
    Anjomrouz M; Sadeghi M; Haddadi A
    J Appl Clin Med Phys; 2013 Jul; 14(4):4298. PubMed ID: 23835393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.
    Currier B; Munro JJ; Medich DC
    Med Phys; 2013 Aug; 40(8):080701. PubMed ID: 23927294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Monte Carlo photon transport simulation in characterizing brachytherapy dosimeter energy-response artefacts.
    Das RK; Li Z; Perera H; Williamson JF
    Phys Med Biol; 1996 Jun; 41(6):995-1006. PubMed ID: 8794480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A secondary air kerma strength standard for Yb-169 interstitial brachytherapy sources.
    Das RK; Mishra V; Perera H; Meigooni AS; Williamson JF
    Phys Med Biol; 1995 May; 40(5):741-56. PubMed ID: 7652005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioactivity measurements of ytterbium-169 brachytherapy sources.
    MacPherson MS; Battista JJ
    Australas Phys Eng Sci Med; 1998 Mar; 21(1):18-23. PubMed ID: 9633149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental validation of Monte Carlo dose calculations about a high-intensity Ir-192 source for pulsed dose-rate brachytherapy.
    Valicenti RK; Kirov AS; Meigooni AS; Mishra V; Das RK; Williamson JF
    Med Phys; 1995 Jun; 22(6):821-9. PubMed ID: 7565373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo-aided dosimetry of the new Bebig IsoSeed 103Pd interstitial brachytherapy seed.
    Daskalov GM; Williamson JF
    Med Phys; 2001 Oct; 28(10):2154-61. PubMed ID: 11695778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.